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The virus of Venezuelan equine encephalomyelitis was isolated and identi- 
fied in 1938 by Kubes and Rios (1) and by Beck and Wyckoff (2).  Although 
the disease produced in horses by this virus is similar to that caused by the 
Eastern  and  Western  equine  encephalomyelitis  viruses,  neutralization  as 
well  as  cross-protection  tests  have  shown  that  the  Venezuelan  virus  is  im- 
munologicaUy different from the other types.  Venezuelan equine encephalo- 
myelitis in man may have been suspected previously (3)  but it has not been 
described.  The  observations  reported  herein  constitute  the  first  evidence 
that the virus of Venezuelan equine  encephalomyelitis may be the  causative 
agent of an illness in man;  they also bring  to light  one of the few instances 
in  which  an  encephalitis-producing  virus  has  been  isolated  from  the  naso- 
pharynx of a patient and from human blood. 
Clinical Data 
Case 1.--A., female, aged 24 years, a laboratory assistant who for 2 months had 
been working with Venezuelan  equine  encephalomyelitis  virus, became ill on Nov. 6, 
1942.  That morning she felt chilly and during the day developed malaise, headache, 
and a "tight" feeling in her chest.  In the afternoon she was seen by a physician who 
found that her temperature was 103°F.  Her pulse rate was 112, her respirations 22 
per minute.  Examination revealed no other evidence  of disease.  White blood cells 
numbered 8,400 per c.mm., of which 88 per cent were granulocytes. 
On Nov. 7, when she was admitted to the Hospital of The Rockefeller Institute, 
* These investigations were aided through the Commission  on Neurotropic Virus 
Diseases,  Board for the Investigation and Control of Influenza and Other Epidemic 
Diseases  in the Army, Preventive Medicine  Division, Office of the Surgeon  General, 
United States Army. 
:~ The Bureau of Medicine  and Surgery of the United States Navy does not neces- 
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the patient insisted that she felt well except for mild headache.  Her temperature was 
100.2°F.  The pulse and respiratory rates were 96 and 22 respectively.  She was alert, 
cooperative, and in no apparent distress.  The nasal mucous membranes were con- 
gested and  the pharynx was  slightly inflamed.  Small, non-tender,  cervical lymph 
nodes were palpable bilaterally.  No disturbances referable to the central nervous 
system or other abnormal physical findings were detected at this time or later.  Roent- 
genograms of the chest revealed no abnormalities on this or on subsequent occasions. 
Cultures of blood remained sterile.  The erythrocyte sedimentation was 9  ram.  at 
the end of 1 hour (Wintrobe method).  The hematocrit was 40 per cent.  The leu- 
cocytes numbered 3,850  per c.mm.  Cultures from the nose and throat yielded no 
organisms of pathogenic significance.  From a specimen of defibrinated whole blood 
and from nasopharyngeal washings obtained at the time of admission, a  virus was 
isolated the nature of which was subsequently investigated. 
The patient's illness was brief and  uneventful.  Her  temperature  rose  to  102°F. 
on the day of admission but returned to normal on Nov. 8.  Her headache subsided 
and no other symptoms or signs of disease appeared.  She returned to her home on 
Nov. 9, where she experienced no difficulty other than mild headaches each morning 
for several days.  She resumed work on Nov. 13.  Although a physical examination 
on  that  day revealed no  abnormalities, roentgenograms  suggested clouding of the 
frontal and ethmoid sinuses.  Subsequently, however, she was symptom-free and on 
repeated visits to the hospital seemed entirely well.  Additional specimens of blood 
were obtained for serological studies. 
Case 2.--C., male, aged 31 years, who also had been working with Venezuelan equine 
encephalomyelitis virus for 2 months in the same laboratory with A., likewise became 
ill on Nov. 6, 1942.  His chief complaints were drowsiness, chilly sensations, and fever. 
He found his temperature was 102°F.  and went to bed.  On Nov. 7 his temperature 
rose to 103.5°F.  and his pulse rate averaged about 100 per minute.  Drowsiness con- 
tinued, unaccompanied, however, by headache or any other complaint.  On Nov. 8 
his temperature was still 101°F.  and he remained in bed, although by this time he felt 
well.  On Nov. 10 he became ambulatory and on the following day returned to work. 
He did not consult a physician during his illness and it was not until much later that 
a specimen of convalescent serum was obtained.  Although no blood had been drawn 
during the febrile  period of  the patient's  illness, a  specimen of  serum obtained  8 
months  previously  was  fortunately  available.  During  the  interval  between  this 
bleeding and the onset of illness on Nov. 6, the patient had enjoyed uninterrupted 
good health. 
Isolation of a Filterable Agent from the Blood 
The  supernatant  serum  of  defibrinated  blood drawn from  patient A.  (Case  1) 
on Nov. 7 was inoculated into six Swiss mice by the intracerebral route.  3 days later 
three of the mice were found dead, and the other three appeared to be sick.  The sick 
mice were killed, their brains removed aseptically, and made into a  10 per cent sus- 
pension in 10 per cent rabbit serum saline.  This material, hereinafter referred to as 
mouse passage No. 1, was stored in the CO2 ice box at -  76°C. and was used for a second 
mouse passage by the intracerebral route. 
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inoculation, they were killed and  their organs  removed.  Cultures  of their brains, 
lungs, livers, spleens, and blood showed no bacterial growth.  A 2 per cent suspension 
of brain tissue from these mice was prepared in 10 per cent rabbit serum saline and 
centrifuged at 2000 R.P.M. for 10 minutes.  The supernate was then filtered through a 
Berkefeld N  candle and the filtrate inoculated intracerebrally into six Swiss mice.  2 
days later three of these mice were dead and the other three were sick.  The  sick 
animals were killed and their brains stored in the COs ice box (passage No. 3--Berke- 
feld N-filtered). 
Several  mice  were  inoculated  intracerebrally  with  the  material  designated  as 
passage No.  1.  These  animals were killed when  they appeared sick 2  days later. 
Their brains were removed and made into a 2 per cent emulsion in rabbit serum saline. 
This was centrifuged at 2000 R.P.M. for 10 minutes and then filtered through a  Seitz 
pad.  Some of this filtrate was inoculated intracerebrally into additional Swiss mice 
which became ill in 2 days and were killed.  A 10 per cent emulsion was prepared with 
the brains of these mice in  10 per cent rabbit serum saline and stored in the CO2 
ice box as passage No. 3 (Seitz-filtered). 
Essentially the  same results have been consistently reproduced by intracerebral 
inoculation of Swiss mice, employing any of the materials designated as passage No. 
1, passage No. 3 (Berkefeld N-filtered), and passage No. 3 (Seitz-filtered). 
Isolation  of a Filterable Agent from Nose and Throat Washings 
Nose and throat washings in a  menstruum consisting of equal parts of broth and 
physiological saline were collected from patient A.  (Case  1).  Part of this material 
was frozen and stored in the COs ice box, a  portion was cultured upon a blood agar 
plate, and 0.5 cc. was injected into a mouse by the intraperitoneal route.  No colonies 
of pathogenic organisms were recognized in the bacterial flora which grew upon the 
blood agar plate.  The mouse was found dead 2 days after injection; washings of the 
peritoneal cavity revealed no bacterial organisms in stained films and proved sterile 
on culture.  The lungs of this animal were removed, made into a 2 per cent emulsion, 
and filtered through a Berkefeld N  filter.  The filtrate was inoculated intracerebrally 
into six Swiss mice which became ill and died within 3 days in a manner indistinguish- 
able from that of the mouse inoculated with the strain of virus isolated from the blood 
of patient A.  Subsequently both strains of virus were proved to be identical. 
A filterable agent was thus isolated from the blood and from the nasopharynx 
of patient A.,  which  was  readily transmissible in  and  highly pathogenic for 
Swiss mice.  The next problem was to establish its identity. 
Identification  of the Filterable Agent 
As a preliminary step in the identification of the agent isolated from patient 
A., an investigation" was undertaken  to determine its degree of pathogenicity 
for available laboratory animals. 
Two guinea pigs were inoculated intracerebrally with material from the previously 
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suspension;  both were dead within 48 hours.  A rabbit given 0.3 cc. of the same sus- 
pension intracerebrally likewise  became sick  and died within 48 hours.  A  second 
rabbit inoculated with the same preparation on the  scarified  cornea appeared sick 
during the  morning of the  2nd  day following  inoculation and  died that afternoon 
with no apparent local lesion in the cornea.  In mice the agent was highly virulent 
and lethal, not only by the intracerebral route in dilutions  of l0  -9 and l0  -1° but also 
on subcutaneous or intraperitoneal injection in dilutions of at least l0  -4. 
The effect of this agent on experimental animals strongly suggested that it 
belonged  in  the  equine  encephalomyelitis group  of viruses.  Further  identi- 
fication of the agent isolated from patient A. was established by complement- 
fixation  and  neutralization  tests.  The  complement-fixation tests  were  con- 
ducted according to a method previously described by Casals and Palacios (4). 
In order to obtain an immune serum against the agent from patient A., a group of 
fifteen  mice approximatdy 50  days of age were injected  with formolized  material 
from one of the early mouse brain passages.  Each mouse received two injections  of 
0.5 cc. of a  10 per cent mouse brain suspension  made inactive by the addition of 0.5 
per cent formalin.  15 days later the mice were anesthetized with ether and bled from 
the heart.  The blood specimens  were pooled,  and the serum, designated as A.-im- 
mune mouse serum, was stored in the CO2 ice box.  At the same time, complement- 
fixing antigens were prepared from both strains of virus isolated from patient  A., 
employing the method described  elsewhere  (4). 
To determine the identity of the two strains of virus isolated from patient 
A.,  complement-fixation tests  were  carried  out  in  which  both  strains  were 
tested with the homologous mouse serum described above, as well as with  a 
number of sera obtained from animals which had been hyperimmunized against 
other  neurotropic viruses.  These included  the viruses of Venezuelan equine 
encephalomyelitis,  lymphocytic  choriomeningitis,  Russian  spring-summer 
encephalitis, louping ill,  Japanese B  encephalitis,  St. Louis encephalitis, West 
Nile encephalitis, and Eastern and Western equine encephalomyelitis.  Simi- 
larly the homologous mouse serum described above was tested against antigens 
prepared from the two strains of A. virus and from the heterologousviruses 
specified.  The results of these tests are given in Table I. 
It is evident that antigens prepared from the laboratory strain of Venezuelan 
equine  encephalomyelitis  virus  I  and  the  two  strains  of  virus  isolated  from 
patient  A.  cross-reacted with  their  respective sera  and  failed  completely to 
react  with  immune  sera  prepared  against  other  neurotropic  viruses.  Simi- 
larly, the immune sera prepared against the standard Venezuelan strain and 
I The strain of Venezuelan  equine  encephalomyelitis virus used in this study was 
kindly sent to Dr. ~ohn R. Patti by Dr. Vladimir Kubes, Director, Institute of Veteri- 
nary Research, Caracas, Venezuela,  and made available to us through the agency of 
the Commission  on Neurotropic Virus Diseases  of the United States Army. J'.  CASALS~ E.  C.  CURNEN~ AND  L.  THOMAS  525 
the  strain of  A.  virus cross-reacted  only with  their  respective antigens and 
failed to react with antigens prepared from other neurotropic viruses. These 
TABLE I 
Results of Complement-Fixation  Tests with Hyperimmune  Animal Sera and Neurotropic 
Virus Antigens 
Hyperlmmune  serum 
against 
Virus 
Venezuelan E.E. 
Patient A. (from 
blood) 
L.C.M. 
Russian  s-s  encepha- 
litis 
Louping ill 
Japanese  B  encepha- 
litis 
St.  Louis  encepha- 
litis 
West  Nile  encephalitis 
W.E.E. 
E.E.E. 
Titers of 
A.  ---  A  I(froml  ILC 
(from [  nose  IV.E.E.I  ~  " 
blood)  and  [ 
_lo=,l_l  _  _ 
1/321 1/321 1/641  0 
1/4,1/8[1/161  o 
0  0  [  11/121~ 
°o  °11 
0  0  , 
0  . 
0 
o  iol 
sera against indicated antigens 
Rus- Loup- ~'ap.  St.  W.  W.E. 
olloo  0 
1/~  1/64  l/S: 
1/s2 
0  1/128 1/128 
I  I  o  I  11/2 
E.E.E. 
0 
0 
0 
1/128 
The hyperimmune sera were prepared by the immunization of mice in the case of all the 
viruses listed with the exception of Western and Eastern equine encephalomyelitis viruses 
for which specific sera were prepared in guinea pigs. 
The virus antigens indicated include A. from blood and A. from nose and throat, strains 
of virus isolated respectively from the blood and nose and throat washings of patient A.; 
V.E.E.  (Venezuelan equine  encephalomyelitis);  L.C.M.  (lymphocytic  choHomeningitis); 
Russian (Russian spring-summer encephalitis); louping ill; Jap. B. (Japanese B encephalitis); 
St. Louis (St. Louis encephalitis); W. Nile (West Nile encephalitis); W.E,E. (Western equine 
encephalomyelitis), and E.E.E. (Eastern equine encephalomyelitis). 
The serum titers are given as a fraction representing the highest dilution of serum showing 
a 2-4- or better fixation of complement.  0 indicates no fixation.  Blank spaces represent 
combinations of sera and antigens that were not tested.  The first tube in all tests contained 
serum undiluted or in a dilution of 1 to 2. 
observations indicate that  the  two  strains of  virus derived from patient A. 
were indistinguishable  by means of complement-fixation tests from the virus 
of Venezuelan equine encephalomyelitis. 
Further  evidence suggesting that both  strains  of  the  agent  isolated  from 
patient  A.  were,  indeed,  Venezuelan  equine  encephalomyelitis virus  was 
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Blood specimens were obtained from patient A. after intervals of 1,  14,  40, and 68 
days from the onset of illness.  A  sample of serum obtained 2 months prior to illness 
was also available. 
As noted previously, patient  C. escaped clinical attention  until long after he had 
recovered.  Fortunately a specimen of serum obtained 8 months before his illness had 
been preserved in the CO2 ice box and hence was available for testing.  Another speci- 
men of serum from patient C. was taken 62 days after the onset of illness. 
Three sera for control purposes were obtained from persons who gave no history of 
illness but who at one time or another had worked in the laboratory with the virus of 
Venezuelan  equine  encephalomyelitis. 
TABLE II 
Results of Complement-Fixation Tests witk Human Sera and Neurotropic Virus Antigens 
Subject 
Patient A. 
~c  C. 
No. 3* 
Serum  Titers of sera against indicated antigens 
Day of bleeding 
Pre-infection'. 2 mos. 
Post-infection:  lday 
"  "  14 days 
~*  ~  40  ~* 
"  "  68  " 
Pre-infection 8 mos. 
Post-infection 62 days 
Vene- 
zuelan 
E.E. 
0 
0 
0 
178 
1/2 
0 
1/4 
0 
0 
0 
A. 
virus  Jap- 
(from  anese 
B  blood) 
0  0 
0  0 
0  0 
1/2  o 
1/2 
0  0 
1/2  o 
0  0 
0 
0 
Russian Louping 
enceph-  ill  I 
alitis 
0 
0 
1/8 
L.C.M. 
st. 
Louis 
enceph  - 
Miffs 
The serum titers are given as a fraction representing the highest dilution of serum showing 
a 2+ or better fixation of complement.  0 indicates no fixation; blank spaces represent com- 
binations of sera and antigens that were not tested.  The first tube in all tests contained 
undiluted serum. 
* Control human  serum. 
The results of complement-fixation tests with these human sera are presented 
in Table II. 
It is apparent that the sera collected from patient A. 2 months before as well 
as 1 and 14 days after the onset of illness failed to react with any of the virus 
antigens  tested,  including  the homologous strain  isolated from the  blood of 
patient A. and the standard laboratory strain of Venezuelan equine encephalo- 
myelitis virus.  On the other hand, sera obtained from patient A. 40 and 68 
days after the onset of illness did react positively but only with the antigens 
of the homologous A. and the standard Venezuelan strains of equine encephalo- 
myelitis virus.  The 40th  day  serum  reacted  in  dilutions  of  1/8  and  1/2  re- 
spectively against  the  standard  and  homologous  virus  antigens,  whereas  the 
68th  day  serum reacted in a  dilution of 1/2  against both. J.  CASALS, E.  C.  CURNEN,  AND  L.  THOMAS  527 
The serum obtained from patient C. 8 months prior to illness gave no reac- 
tion with  any of the antigens  tested,  whereas  serum obtained 62  days after 
the onset of illness reacted specifically with the standard Venezuelan and A. 
strain antigens in dilutions of 1/4 and 1/2 respectively.  The control human 
sera  Nos.  3,  4,  and  5  were  found  to  have  no  complement-fixingantibodies 
against any of the virus antigens  tested with  the exception of serum No. 3, 
which reacted in a  dilution of 1/8 with louping ill virus.  This result was ex- 
pected,  however, as serum No.  3  was derived from a  person who had had a 
laboratory infection with louping ill virus in 1933 (5) and his blood serum was 
known  to  contain  specific complement-fixing antibodies  (4).  The  results  of 
these  complement-fixation tests with  human  sera further  identify  the  agent 
isolated from patient A.  as a  strain  of Venezuelan  equine  encephalomyelitis 
virus.  Of still greater significance,  the development of specific antibodies in 
the sera of patients A. and C. following an acute febrile illness strongly suggests 
that the virus isolated from patient A. was the causative agent of the disease 
in both instances. 
Additional evidence was provided by the results of neutralization tests which 
showed that specific antibodies not only appeared in the sera of these patients 
following their febrile illnesses but also attained exceedingly high titer.  Sera 
obtained from patient A. on the 1st and 40th day and from patient C. on the 
62nd day after the onset of illness, as well as a control specimen (No. 5), were 
tested in mice for the presence of  neutralizing antibodies against the standard 
strain of Venezuelan equine encephalomyelitis virus. 
Technique of Neutralization Tests 
48 hours after intracerebral inoculation with active Venezuelan virus, two mice were 
killed; their brains were removed, ground in a mortar, and emulsified in 10 per cent 
rabbit serum saline to a concentration of 10  -x.  This emulsion was centrifuged at 2000 
R.P.M. for 10 minutes.  The supernate was drawn off and in the same diluent made 
into serial tenfold dilutions  beginning  with I to 50.  These virus dilutions  were then 
mixed with undiluted sera in equal volumes of 0.2 cc. each,  making a series of final 
virus dilutions ranging from 10  -~ to 10  -I°.  The serum-virus mixtures were incubated 
for 2 hours at 37°C. in a water bath and finally were inoculated intracerebrally into 3 
weeks old Swiss mice, each mouse receiving an inoculum of 0.03 cc.  Surviving mice 
were discarded  after 21 days of observation. 
The results  of the neutralization  tests are shown  in Table III.  The  titer 
(50  per  cent  mortality  end-point)  of  Venezuelan  equine  encephalomyelitis 
virus  combined with  normal,  human  control  serum  No.  5  was  10  -l°.  The 
serum from patient A. obtained 1 day after the onset of illness did not contain 
any neutralizing antibody against the virus since all mice inoculated with this 
virus-serum combination died,  including  those  receiving the  10  -9 virus dilu- 
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from the onset of illness contained  sufficient antibody  to reduce  the  titer of 
virus to 10  -5.e7, indicating a  neutralization  of more than  10,000  lethal doses. 
In a  similar fashion, the serum obtained from patient C. on the 62nd day fol- 
lowing  the  onset of his  illness had  sufficient antibody  to reduce  the  titer  of 
Venezuelan  virus  to  10-~.u--a  neutralization  of  over  100,000  lethal  doses. 
The high neutralizing  antibody titers of the convalescent sera from the  two 
patients are unequivocal, and are especially significant in the case of A. from 
whom  strains  of the virus were isolated  and  whose  serum during  the  acute 
phase of illness contained  no antibody whatever. 
TABLE III 
Results of Neutralization  Tests with Venezuelan Equine Encephalomyelitis  Virus and 
Human Sera 
I 
Subject  I 
I 
--.I 
'afient A. ! 
i 
cc  c¢  ! 
~  C. 
70.5 
(control) 
Serum 
Day of bleeding 
Post-infection:  lday 
"  "  40 days 
"  "  62  " 
Fate of mice followln~[  intracerebral 
injection of  serum-mrus mixture* 
Dilution of virus 
10-* 
i/4 
4/4 
10-'* 
4/4 
4/4 
10-1 10-a 10-~ to-  B 10-9  10-to 
4/4 ~/4 4/4 4/4 4/4 
4/4 1/4 0/4 0/4 
1/4 I/4 0/4 0/4 
4/4 ~/4 4/4 4/4 $/4 2/4 
Titer of virus~ 
10--9.50 
(or more) 
10-5.67 
10-4.84 
10-10.0 
Neutral 
ization 
index§ 
< 
21,38 
144,6C 
* Fate of mice is indicated by a fraction, the denominator of which signifies the number of 
mice injected with each serum-virus combination and  the numerator  the number of mice 
which died. 
~t Tiler of virus is given as the highest virus dilution giving a 50 per cent mortality. 
§ Neutralization index is the ratio between the titer of virus obtained with each of the sera 
tested and the tiler of virus found with the normal human control serum. 
These data conclude the evidence to show that the agents isolated from the 
blood and from nasopharyngeal washings  of a  patient  (A.)  during  an acute 
febrile illness were strains of Venezuelan equine  encephalomyelitis virus and 
that this virus was very probably the causative agent not only of her disease 
but presumably also of the similar illness contracted  simultaneously by her 
fellow laboratory worker  (C.). 
DISCUSSION 
Although the occurrence of equine encephalomyelitis in man was suspected 
as early as 1931 (6), it was not until 1938 that the diagnosis was established in- 
dependently  by  actual  isolation  of  Eastern  equine  encephalomyelitis  virus 
from the brains of fatal human cases by Fothergill, Dingle, Farber, and Conner- 
ley (7) and by Webster and Wright (8).  Somewhat later, Howitt (9) reported ~'. CASALS,  E. C. CURNEN,  AND  L. THOMAS  529 
that she had isolated the virus of Western equine encephalomyelitis from the 
brain  of  a  fatal  human  case.  In  these  instances,  as  in  many subsequent 
reports,  equine encephalomyelitis viruses isolated from human sources were 
usually derived from tissues of the central nervous system following death of 
the patient.  In 1939, however, Fothergill, Holden, and Wyckoff (10) reported 
a  fatal case of proved Western equine encephalomyelitis, whose spinal fluid 
obtained on the day before death produced paralysis and death when injected 
intracerebrally into young mice and guinea pigs.  In the same year, Howitt 
(11)  succeeded in isolating Western equine encephalomyelitis virus from the 
blood of a patient during life. 
No evidence is available, howev4r, concerning the occurrence of Venezuelan 
equine encephalomyelitis in man.  Prior to this report, the virus had not been 
isolated from a  human source.  Furthermore,  no data have been published 
to indicate whether disease due to this agent occurs in human beings or whether 
circulating antibodies are demonstrable  in persons living in areas  where  the 
disease is prevalent in horses. 
Certain implications of the observations herein presented seem  worthy of 
additional comment.  In the first place,  the illness produced by Venezuelan 
equine encephalomyelitis virus in the two patients reported was brief and mild, 
not at all so severe as the disease occurring naturally in horses nor that pro- 
duced experimentally in other animals.  Moreover, it was strikingly less severe 
than in most of the reported clinical cases of human infection with other types 
of equine encephalomyelitis virus. 
Finally,  the  concept  that  a  virus,  ordinarily considered  to  be  primarily 
neurotropic and encephalopathic, can produce a  mild form of generalized in- 
fection which nevertheless promotes an immune response in the human host 
is not new (12), but in the present instance (of patient A.) is strikingly exempli- 
fied.  The fact that the virus was readily isolated not only from the patient's 
blood but also from the nasopharynx would seem to bear in a significant way 
upon the epidemiology of neurotropic virus diseases in general, and the equine 
encephalomyelitis group in particular. 
SUMMARY  AND  CONCLUSION 
A filterable agent was isolated from the blood and from washings of the upper 
respiratory passages of a young laboratory worker during a mild, acute, febrile 
illness.  This agent was identified as a  strain  of  Venezuelan equine  enceph- 
alomyelitis  virus.  Circulating  specific  complement-fixing and  neutralizing 
antibodies not present in  sera  withdrawn during  the  acute phase  of  illness 
were demonstrated in sera obtained during convalescence.  A fellow laboratory 
worker who became similar|y ill simultaneously also  developed  during  con- 
valescence specific  circulating antibodies not present prior  to illness. 530  VENEZUELAN EQUINE ENCEPHALOMYELITIS  IN  MAN 
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